Delivery Order SPE2DB24D8003-SPE2DB25FJUUT

Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,337.68, is for the delivery of Trulicity 3 mg/0.5 ml pens with a completion date of April 17, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies, particularly the U.S. Armed Forces. The company holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,487.31 contract is for the delivery of Trulicity 1.5 mg/0.5 mL pens, a medication used to treat diabetes. The award is issued under Dakota Drug's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables,...
This is a $2,225.67 firm fixed price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract was awarded by the Defense Logistics Agency (DLA) for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA Troop Support Medical's ECAT Generation V Program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,579.40, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This contract is not associated with a set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of the medication Trulicity 0.75 mg/0.5 ml pen, 0.5 ml, with a ceiling value of $3,690.54 and a completion date of May 20, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of Trulicity 3 mg/0.5 ml pen 0.5 ml, a diabetes management product, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,312.08 and a period of performance through May 30, 2025. Dakota Drug, Inc. holds a significant single-award...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The $1,261.34 contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, which are used to treat diabetes. This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,650.43 contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a completion date of May 23, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA as part of the ECAT Generation V Program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $1,906.50, is for the supply of 4.5 mg/0.5 ml Trulicity pens, a medication used to treat diabetes. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has a ceiling value of $1,873.80 and is a firm fixed price delivery order with a period of performance ending on May 22, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJUUT
    Delivery Order

This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,003.24 order is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml.

The award is part of Dakota Drug's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This contract originated from DLA Troop Support Medical's solicitation SPE2DH-21-R-0002 for commercial medical equipment, accessories, consumables, and medical simulation equipment.

The order does not have a set-aside designation and is expected to be completed by July 16, 2025. This contract demonstrates Dakota Drug's strategic importance as a critical vendor for medical procurement, particularly for supporting the DLA's military healthcare facilities.

Generated 10/14/25, 10:53 AM